skip to main content

Chemistry, part 3

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate > oligosaccharide > n-[(2r,3r,4r,5r,6r)-2-[(2r,3s,4s,5r,6s)-3,5-dihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]-6-[(2r,3s,4r,5r)-4,5,6-trihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]oxyoxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate > oligosaccharide > n-[(2r,3r,4r,5r,6r)-2-[(2r,3s,4s,5r,6s)-3,5-dihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]-6-[(2r,3s,4r,5r)-4,5,6-trihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]oxyoxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate > oligosaccharide > n-[(2r,3r,4r,5r,6r)-2-[(2r,3s,4s,5r,6s)-3,5-dihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]-6-[(2r,3s,4r,5r)-4,5,6-trihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]oxyoxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide > n-[(2r,3r,4r,5r,6r)-2-[(2r,3s,4s,5r,6s)-3,5-dihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]-6-[(2r,3s,4r,5r)-4,5,6-trihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]oxyoxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide > n-[(2r,3r,4r,5r,6r)-2-[(2r,3s,4s,5r,6s)-3,5-dihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]-6-[(2r,3s,4r,5r)-4,5,6-trihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]oxyoxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > glycan > oligosaccharide > n-[(2r,3r,4r,5r,6r)-2-[(2r,3s,4s,5r,6s)-3,5-dihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]-6-[(2r,3s,4r,5r)-4,5,6-trihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]oxyoxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

Preferred term

n-[(2r,3r,4r,5r,6r)-2-[(2r,3s,4s,5r,6s)-3,5-dihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]-6-[(2r,3s,4r,5r)-4,5,6-trihydroxy-2-[[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]oxyoxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C32H55NO24

inchi

  • InChI=1S/C32H55NO24/c1-7-14(36)19(41)23(45)30(51-7)49-5-11-17(39)27(57-29-13(33-9(3)35)18(40)16(38)10(4-34)54-29)25(47)32(55-11)56-26-12(53-28(48)22(44)21(26)43)6-50-31-24(46)20(42)15(37)8(2)52-31/h7-8,10-32,34,36-48H,4-6H2,1-3H3,(H,33,35)/t7-,8-,10+,11+,12+,13+,14+,15+,16-,17-,18+,19+,20+,21+,22+,23-,24-,25+,26+,27-,28?,29+,30+,31+,32-/m0/s1

inchikey

  • ZCZBACQXYWQNIT-GNMPKXMOSA-N

mass

  • 837.775

monoisotopicmass

  • 837.31140

smiles

  • O([C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@@H]1O)CO[C@@H]2O[C@H]([C@@H](O)[C@@H](O)[C@@H]2O)C)O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO[C@@H]4O[C@H]([C@@H](O)[C@@H](O)[C@@H]4O)C)[C@H]5O[C@@H]([C@H](O)[C@H](O)[C@H]5NC(=O)C)CO

subset

  • 2_STAR

synonym RELATED

  • 2-acetamido-2-deoxy-alpha-D-galacto-hexopyranosyl-(1->3)-[6-deoxy-alpha-L-galacto-hexopyranosyl-(1->6)]-beta-D-galacto-hexopyranosyl-(1->4)-[6-deoxy-alpha-L-galacto-hexopyranosyl-(1->6)]-D-gluco-hexopyranose
  • GalNAc(a1-3)[Fuc(a1-6)]Gal(b1-4)[Fuc(a1-6)]Glc
  • WURCS=2.0/4,5,4/[a2122h-1x_1-5][a2112h-1b_1-5][a2112h-1a_1-5_2*NCC/3=O][a1221m-1a_1-5]/1-2-3-4-4/a4-b1_a6-e1_b3-c1_b6-d1

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:155657

Download this concept:

RDF/XML TURTLE JSON-LD